- Home
- ETON vs PFLT Comparison
ETON vs PFLT Comparison
Compare ETON & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | PFLT |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.8M | 805.6M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ETON | PFLT |
|---|---|---|
| Price | $30.29 | $8.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $39.33 | $10.50 |
| AVG Volume (30 Days) | 343.5K | ★ 970.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | $8.16 |
| Revenue Next Year | $47.23 | N/A |
| P/E Ratio | ★ N/A | $24.14 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $7.68 |
| 52 Week High | $32.31 | $10.88 |
Technical Indicators
Market Signals| Indicator | ETON | PFLT |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 48.96 |
| Support Level | $16.17 | $8.47 |
| Resistance Level | $32.31 | $9.36 |
| Average True Range (ATR) | 1.54 | 0.19 |
| MACD | 0.26 | -0.04 |
| Stochastic Oscillator | 79.33 | 23.60 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.